RARRES2 and ovarian cancer: First, results showed that mean levels of chemerin and CMKLR1 were elevated in ovarian cancers with higher cytoplasmic ERβ expression when compared to the lower expressing subgroup (p = 0.0143 and p = 0.0133, respectively) (Table 3).